Stockscreener 앱 받기
117.15
0.42%
-0.50
시간 외 거래:
117.15
Merck Co Inc 주식(MRK)의 최신 뉴스
Merck & Co., Inc. $MRK Shares Sold by Wesbanco Bank Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Applied Finance Capital Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ProShare Advisors LLC - MarketBeat
Rockland Trust Co. Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Midwest Trust Co Purchases 24,910 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rothschild & Co Redburn Adjusts Price Target on Merck & Co. to $140 From $135, Maintains Buy Rating - marketscreener.com
Merck & Co., Inc. $MRK Position Increased by Providence Capital Advisors LLC - MarketBeat
Costello Asset Management INC Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
Should You Buy Moderna Before Feb. 13? - The Motley Fool
Insider Sell: Chirfi Guindo Sells 10,000 Shares of Merck & Co In - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP Sells $14,485,422.95 in Stock - MarketBeat
Chirfi Guindo Sells 10,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck: The Spike Doesn't Make It Overvalued (NYSE:MRK) - Seeking Alpha
Merck Stock Surged 40% Last Year. Is it Still a Buy in 2026? - TIKR.com
Merck: A Buy For 2026, But The Clock Is Still Ticking (NYSE:MRK) - Seeking Alpha
Oppenheimer Asset Management Inc. Has $46.50 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Alps Advisors Inc. Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Reduced by Candriam S.C.A. - MarketBeat
From Bargain To Balancing Act: Merck's Next Test Begins (Rating Downgrade) - Seeking Alpha
Merck: Pipeline Building Despite The Light FY26 Guide, Major Momentum - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Cut to "Buy" at Wall Street Zen - MarketBeat
Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface - TechStock²
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Merck & Co., Inc. $MRK Shares Bought by Canada Post Corp Registered Pension Plan - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Garland Capital Management Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Prime Capital Investment Advisors LLC - MarketBeat
Insider Sell Alert: Johannes Oosthuizen Sells 15,000 Shares of M - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP David Michael Williams Sells 5,000 Shares - MarketBeat
Johannes Jacobus Oosthuizen Sells 15,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) CFO Caroline Litchfield Sells 41,997 Shares - MarketBeat
Merck And Company Inc (NYSE:MRK) Healthcare Momentum In S&P 500 Today - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Shares Up 1.8% Following Analyst Upgrade - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $140.00 - MarketBeat
Willis Investment Counsel Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Guggenheim Adjusts Price Target on Merck & Co to $140 From $122, Maintains Buy Rating - marketscreener.com
Merck & Co., Inc. $MRK Holdings Cut by Fishman Jay A Ltd. MI - MarketBeat
Bessemer Group Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.1% on Analyst Upgrade - MarketBeat
Scotiabank Lifts Merck (MRK) Target as Execution Continues to Impress - Finviz
Merck stock rises 2% in New York as MRK traders size up outlook and a fresh RSV approval - TechStock²
Merck veteran Perlmutter-led Eikon Therapeutics valued at $860 million in Nasdaq debut - Reuters
Savant Capital LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Triglav Investments D.O.O. - MarketBeat
Envestnet Asset Management Inc. Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
ABN AMRO Bank N.V. Acquires 37,932 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Lowered by Homestead Advisers Corp - MarketBeat
Merck & Co., Inc. $MRK Position Increased by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Merck Veteran-Led Eikon Therapeutics Raises $381 Million in IPO - Bloomberg
Merck & Co., Inc. (NYSE:MRK) Trading 2.2% Higher Following Earnings Beat - MarketBeat
Where is Merck & Co. (MRK) headed according to Wall Street? - MSN
Jim Cramer on Merck & Co.: “This is one of my favorite pharmaceutical stocks” - MSN
Jim Cramer on Merck & Co.: "This Is One of My Favorite Pharmaceutical Stocks" - Finviz
Jim Cramer on Merck & Co.: “This Is One of My Favorite Pharmaceutical Stocks” - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $120.00 at Citigroup - MarketBeat
Merck & Co Inc (NYSE:MRK) Tops Estimates - FXDailyReport.Com
Looking Into Merck & Co Inc's Recent Short Interest - Benzinga
Cantor Fitzgerald Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Wells Fargo & Company Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q4 2025 Earnings Call Transcript - Insider Monkey
Ashton Thomas Private Wealth LLC Acquires 43,047 Shares of Merck & Co., Inc. $MRK - MarketBeat
Citigroup Adjusts Price Target on Merck & Co to $120 From $115, Maintains Neutral Rating - marketscreener.com
Payne Capital LLC Purchases Shares of 10,540 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Q4 Earnings Call Highlights - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Up 2.2% on Earnings Beat - MarketBeat
Merck Looks Ahead To Phase III-Rich Period As Keytruda Winds Down - Citeline News & Insights
Merck & Co Inc (MRK) Q4 2025 Earnings Call Highlights: Strong Gr - GuruFocus
AI for investors - MLQ.ai
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
2.87%
0.51%
자본화:
|
볼륨(24시간):